Latest Articles

Publication Date
Novel immunotherapy combination approved for endometrial cancer - European Pharmaceutical Review

Novel immunotherapy combination approved for endometrial cancer European Pharmaceutical Review

Published: June 18, 2024, 7 a.m.
This Tucson woman doesn’t trust the AZ GOP to protect access to contraceptives - The Copper Courier

This Tucson woman doesn’t trust the AZ GOP to protect access to contraceptives The Copper Courier

Published: June 18, 2024, 7 a.m.
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval - FiercePharma

Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval FiercePharma

Published: June 18, 2024, 7 a.m.
Merck’s Keytruda regimen granted FDA approval to treat endometrial cancer - PMLiVE

Merck’s Keytruda regimen granted FDA approval to treat endometrial cancer PMLiVE

Published: June 18, 2024, 7 a.m.
FDA Approves Pembrolizumab With Chemotherapy in Advanced Endometrial Carcinoma - AJMC.com Managed Markets Network

FDA Approves Pembrolizumab With Chemotherapy in Advanced Endometrial Carcinoma AJMC.com Managed Markets Network

Published: June 17, 2024, 7 a.m.
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval - Pharmaceutical Technology

AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval Pharmaceutical Technology

Published: June 17, 2024, 7 a.m.
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central

FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central

Published: June 17, 2024, 7 a.m.
AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer - PMLiVE

AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer PMLiVE

Published: June 17, 2024, 7 a.m.
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive

Published: June 17, 2024, 7 a.m.
Film screening in Cork aims to highlight the problems in treatment for Endometriosis - EchoLive.ie

Film screening in Cork aims to highlight the problems in treatment for Endometriosis EchoLive.ie

Published: June 14, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!